Tadalafil Reversed H-89 – and Scopolamine – Induced Spatial Learning Impairments in Male Rats

Abstract

Accumulated evidence shows that the cAMP and cGMP signaling pathway plays an important role in memory function and neuronal plasticity. Phosphodiesterase 5 (PDE5) is a hopeful therapeutic target in AD (Alzheimer disease), and PDE5 inhibition may be a good therapeutic strategy for the treatment of AD. In the present study, the four-day bilateral intra-hippocampal infusion of H-89 as a protein kinase AII inhibitor (10 µM/side) and intra-peritoneal injections of tadalafil (20 mg/kg) and scopolamine (0.5 mg/kg) alone and also on combination on spatial learning in Morris water maze (MWM) were investigated. DMSO and saline were used as controls for H-89 and other mentioned drugs, respectively. Rats were trained for 4 days; each day included one block of four trials. Post- training probe trial tests were performed on day 5. Administration of H-89 and scopolamine led to a significant impairment in spatial learning compared to their related controls. But, combination of tadalafil/H-89 or tadalafil/scopolamine reversed H-89 or scopolamine- induced spatial learning deficits in MWM. Taken together, these results showed the probable regulatory effects of cGMP on cholinergic and cAMP/PKA signaling pathways in co-administrations of these mentioned drugs on spatial learning in MWM.

Key words

cGMP/PKG - morris water maze - spatial learning - PKA II inhibitor - scopolamine

Publikationsverlauf

Eingereicht: 15. August 2020

Angenommen: 22. Dezember 2020

Artikel online veröffentlicht:
15. Januar 2021

• References

• 1 Contestabile A. The history of the cholinergic hypothesis. Behavioural Brain Research 2011; 221: 334-340
• 2 Bartus RT, Dean RR, Beer B. et al. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217: 408-414
• 3 Tohgi H, Abe T, Kimura M. et al. Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia. Journal of Neural Transmission 1996; 103: 1211-1220
• 4 Sarter M, Bruno JP. Cognitive functions of cortical acetylcholine: Toward a unifying hypothesis. Brain Research Reviews 1997; 23: 28-46
• 5 Sunderland T, Tariot PN, Weingartner H. et al. Pharmacologic modelling of Alzheimer’s disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1986; 10: 599-610
• 6 Lochner A, Moolman J. The many faces of H89: A review. Cardiovascular Drug Reviews 2006; 24: 261-274
• 7 Sharifzadeh M, Zamanian A-R, Gholizadeh S. et al. Post-training intrahippocampal infusion of nicotine–bucladesine combination causes a synergistic enhancement effect on spatial memory retention in rats. European Journal of Pharmacology 2007; 562: 212-220
• 8 Guerra GP, Mello CF, Bochi GV. et al. Hippocampal PKA/CREB pathway is involved in the improvement of memory induced by spermidine in rats. Neurobiology of Learning and Memory 2011; 96: 324-332
• 9 Azami K, Etminani M, Tabrizian K. et al. The quantitative evaluation of cholinergic markers in spatial memory improvement induced by nicotine–bucladesine combination in rats. European Journal of Pharmacology 2010; 636: 102-107
• 10 Sharifzadeh M, Sharifzadeh K, Naghdi N. et al. Posttraining intrahippocampal infusion of a protein kinase AII inhibitor impairs spatial memory retention in rats. J Neurosci Res 2005; 79: 392-400
• 11 Eftekharzadeh B, Ramin M, Khodagholi F. et al. Inhibition of PKA attenuates memory deficits induced by beta-amyloid (1-42), and decreases oxidative stress and NF-kappaB transcription factors. Behav Brain Res 2012; 226: 301-308
• 12 Najafi S, Payandemehr B, Tabrizian K. et al. The role of nitric oxide in the PKA inhibitor induced spatial memory deficits in rat: Involvement of choline acetyltransferase. European Journal of Pharmacology 2013; 714: 478-485
• 13 Inoue H, Hase K, Segawa A. et al. H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulphonamide) induces autophagy independently of protein kinase A inhibition. European Journal of Pharmacology 2013; 714: 170-177
• 14 Tabrizian K, Hashemzaei M, Nasiri AA. et al. Interactive involvement of hippocampal cAMP/PKA and cyclooxygenase-2 signaling pathways in spatial learning in the Morris water maze. Folia Neuropathol 2018; 56: 58-66
• 15 Tabrizian K, Musavi S, Rigi M. et al. Behavioral and molecular effects of intrahippocampal infusion of auraptene, resveratrol, and curcumin on H-89-induced deficits on spatial memory acquisition and retention in Morris water maze. Human & Experimental Toxicology 2019; 38: 775-784
• 16 Sharifzadeh M, Sharifzadeh K, Naghdi N. et al. Posttraining intrahippocampal infusion of a protein kinase AII inhibitor impairs spatial memory retention in rats. Journal of Neuroscience Research 2005; 79: 392-400
• 17 Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiological Reviews 1995; 75: 725-748
• 18 Frey U, Huang Y, Kandel E. Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science 1993; 260: 1661-1664
• 19 Son H, Lu Y-F, Zhuo M. et al. The specific role of cGMP in hippocampal LTP. Learning & Memory 1998; 5: 231-245
• 20 Paul C, Schöberl F, Weinmeister P. et al. Signaling through cGMP-dependent protein kinase I in the amygdala is critical for auditory-cued fear memory and long-term potentiation. Journal of Neuroscience 2008; 28: 14202-14212
• 21 Impey S, Mark M, Villacres EC. et al. Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus. Neuron 1996; 16: 973-982
• 22 Lu Y-F, Kandel ER, Hawkins RD. Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus. Journal of Neuroscience 1999; 19: 10250-10261
• 23 Boess FG, Hendrix M, van der Staay F-J. et al. Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance. Neuropharmacology 2004; 47: 1081-1092
• 24 Rutten K, Prickaerts J, Hendrix M. et al. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors. European Journal of Pharmacology 2007; 558: 107-112
• 25 Rutten K, Prickaerts J, Blokland A. Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action. Neurobiology of Learning and Memory 2006; 85: 132-138
• 26 Prickaerts J, Şık A, van Staveren WC. et al. Phosphodiesterase type 5 inhibition improves early memory consolidation of object information. Neurochemistry International 2004; 45: 915-928
• 27 Rutten K, Basile J, Prickaerts J. et al. Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques. Psychopharmacology 2008; 196: 643-648
• 28 van der Staay FJ, Rutten K, Bärfacker L. et al. The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents. Neuropharmacology 2008; 55: 908-918
• 29 Blokland A, Schreiber R, Prickaerts J. Improving memory: a role for phosphodiesterases. Current Pharmaceutical Design 2006; 12: 2511-2523
• 30 Puzzo D, Staniszewski A, Deng SX. et al. Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-β load in an Alzheimer’s disease mouse model. Journal of Neuroscience 2009; 29: 8075-8086
• 31 Cuadrado-Tejedor M, Hervias I, Ricobaraza A. et al. Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer’s disease. British Journal of Pharmacology 2011; 164: 2029-2041
• 32 García-Barroso C, Ricobaraza A, Pascual-Lucas M. et al. Tadalafil crosses the blood–brain barrier and reverses cognitive dysfunction in a mouse model of AD. Neuropharmacology 2013; 64: 114-123
• 33 Khorshidahmad T, Tabrizian K, Vakilzadeh G. et al. Interactive effects of a protein kinase AII inhibitor and testosterone on spatial learning in the Morris water maze. Behavioural Brain Research 2012; 228: 432-439
• 34 Paxinos G, Watson C The Rat Brain in Stereotaxic Coordinates. San Diego. Acad. 1998
• 35 Azami K, Tabrizian K, Hosseini R. et al. Nicotine attenuates spatial learning deficits induced by sodium metavanadate. Neurotoxicology 2012; 33: 44-52
• 36 Sharifzadeh M, Naghdi N, Khosrovani S. et al. Post-training intrahippocampal infusion of the COX-2 inhibitor celecoxib impaired spatial memory retention in rats. European Journal of Pharmacology 2005; 511: 159-166
• 37 Sharifzadeh M, Tavasoli M, Naghdi N. et al. Post-training intrahippocampal infusion of nicotine prevents spatial memory retention deficits induced by the cyclo-oxygenase-2-specific inhibitor celecoxib in rats. Journal of Neurochemistry 2005; 95: 1078-1090
• 38 Malik J, Kumar M, Deshmukh R. et al. Ameliorating effect of lyophilized extract of Butea frondosa leaves on scopolamine-induced amnesia in rats. Pharmaceutical Biology 2013; 51: 233-239
• 39 Klinkenberg I, Blokland A. The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies. Neuroscience & Biobehavioral Reviews 2010; 34: 1307-1350
• 40 Kim S-J, Lee J-H, Chung H-S. et al. Neuroprotective effects of AMP-activated protein kinase on scopolamine induced memory impairment. The Korean Journal of Physiology & Pharmacology 2013; 17: 331-338
• 41 Xiang GQ, Tang SS, Jiang LY. et al. PPARγ agonist pioglitazone improves scopolamine-induced memory impairment in mice. Journal of Pharmacy and Pharmacology 2012; 64: 589-596
• 42 Cheignon C, Tomas M, Bonnefont-Rousselot D. et al. Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Biology 2018; 14: 450-464
• 43 Kotani S, Yamauchi T, Teramoto T. et al. Pharmacological evidence of cholinergic involvement in adult hippocampal neurogenesis in rats. Neuroscience 2006; 142: 505-514
• 44 Phillips HS, Hains JM, Armanini M. et al. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease. Neuron 1991; 7: 695-702
• 45 Huang W, Cao J, Liu X. et al. AMPK plays a dual role in regulation of CREB/BDNF pathway in mouse primary hippocampal cells. Journal of Molecular Neuroscience 2015; 56: 782-788
• 46 Figurov A, Pozzo-Miller LD, Olafsson P. et al. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 1996; 381: 706-709
• 47 Liebenberg N, Harvey BH, Brand L. et al. Chronic treatment with the phosphodiesterase type 5 inhibitors sildenafil and tadalafil display anxiolytic effects in Flinders Sensitive Line rats. Metabolic Brain Disease 2012; 27: 337-340
• 48 Reneerkens OA, Rutten K, Akkerman S. et al. Phosphodiesterase type 5 (PDE5) inhibition improves object recognition memory: Indications for central and peripheral mechanisms. Neurobiology of Learning and Memory 2012; 97: 370-379
• 49 Prickaerts J, Steinbusch HW, Smits JF. et al. Possible role of nitric oxide-cyclic GMP pathway in object recognition memory: Effects of 7-nitroindazole and zaprinast. European Journal of Pharmacology 1997; 337: 125-136
• 50 Jin F, Gong Q-H, Xu Y-S. et al. Icariin, a phoshphodiesterase-5 inhibitor, improves learning and memory in APP/PS1 transgenic mice by stimulation of NO/cGMP signalling. International Journal of Neuropsychopharmacology 2014; 17: 871-881
• 51 Al-Amin MM, Hasan SN, Alam T. et al. Tadalafil enhances working memory, and reduces hippocampal oxidative stress in both young and aged mice. European Journal of Pharmacology 2014; 745: 84-90
• 52 Kulkarni S, Patil C. Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects. Methods Find Exp Clin Pharmacol 2004; 26: 789-799
• 53 Forgue ST, Patterson BE, Bedding AW. et al. Tadalafil pharmacokinetics in healthy subjects. British Journal of Clinical Pharmacology 2006; 61: 280-288
• 54 Vila-Petroff MG, Younes A, Egan J. et al. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circulation Research 1999; 84: 1020-1031
• 55 Rosen RC, Kostis JB. Overview of phosphodiesterase 5 inhibition in erectile dysfunction. The American Journal of Cardiology 2003; 92: 9-18
• 56 García-Osta A, Cuadrado-Tejedor M, García-Barroso C. et al. Phosphodiesterases as therapeutic targets for Alzheimer’s disease. ACS Chemical Neuroscience 2012; 3: 832-844
• 57 Zhu J, Mix E, Winblad B. The antidepressant and antiinflammatory effects of rolipram in the central nervous system. CNS Drug Reviews 2001; 7: 387-398
• 58 Argyrousi EK, Heckman PR, Prickaerts J. Role of cyclic nucleotides and their downstream signaling cascades in memory function: Being at the right time at the right spot. Neuroscience & Biobehavioral Reviews 2020; 113: 12-38
• 59 Liu L, Xu H, Ding S. et al. Phosphodiesterase 5 inhibitors as novel agents for the treatment of Alzheimer’s disease. Brain Research Bulletin 2019; 153: 223-231
• 60 Zhang J, Guo J, Zhao X. et al. Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice. Behavioural Brain Research 2013; 250: 230-237
• 61 Benito E, Barco A. CREB’s control of intrinsic and synaptic plasticity: implications for CREB-dependent memory models. Trends in Neurosciences 2010; 33: 230-240
• 62 França MER, Ramos RKLG, Oliveira WH. et al. Tadalafil restores long-term memory and synaptic plasticity in mice with hepatic encephalopathy. Toxicology and Applied Pharmacology 2019; 379: 114673